相关实验视频
Updated: Jan 9, 2026

06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
5.7K
在遗传性出血端膜切除症方面有什么新鲜事?
1Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
遗传性出血端膜炎 (HHT) 是一种遗传性出血疾病,导致血管异常. 新的疗法正在出现,以改善HHT患者的治疗和生活质量.
科学领域:
- 血管生物学和遗传学
- 血液学 血液学 血液学
- 医学治疗学 医学治疗学
背景情况:
- 遗传性出血性电脉切开症 (HHT) 是一种遗传性血管病,其特征是异常的血管形成.
- 它是第二个最常见的遗传性出血障碍,而表是其标志性症状.
- 由于经常出血,HHT往往导致缺铁性贫血.
研究的目的:
- 审查了解HHT病理生物学,表现和治疗方面的最新进展.
- 突出了新的医疗疗的发展,为HHT.
- 讨论HHT诊断和管理的不断变化的格局.
主要方法:
- 关于HHT的最新科学文献和临床研究的审查.
- 对国际共识治疗指南的分析.
- 对新型HHT疗法的临床前和临床试验数据的检查.
主要成果:
- 在了解HHT病理生物学和临床表现方面取得了重大进展.
- 医疗疗法,包括重新定制的药物和新型药物,正在成为主要的治疗方法.
- 几种新疗法正在开发中,正在临床试验中取得进展.
结论:
- 在过去的十年中,对HHT的理解和治疗取得了相当大的进步.
- 预计新型和新疗法将降低HHT患者的发病率并改善HHT患者的生活质量.
- 提高认识和诊断正在促进HHT管理的快速变化.
更多相关视频
相关概念视频
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Venous Thrombosis IV: Nursing Management
185
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
185
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
418
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
418
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K

